Clin Endosc.  2019 Mar;52(2):168-174. 10.5946/ce.2018.105.

Factors Associated with Malignant Biliary Strictures in Patients with Atypical or Suspicious Cells on Brush Cytology

Affiliations
  • 1Division of Gastroenterology, Department of Internal Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea. drjtj@paik.ac.kr

Abstract

BACKGROUND/AIMS
Pathological diagnosis of biliary strictures with atypical or suspicious cells on endoscopic retrograde brush cytology and indeterminate strictures on imaging is challenging. The aim of this study was to identify markers for malignant strictures in such cases.
METHODS
We retrospectively analyzed data collected from 146 consecutive patients with indeterminate biliary strictures on imaging who underwent endoscopic retrograde brush cytology from 2007 to 2013. Factors associated with malignant strictures in patients with atypical or suspicious cells on brush cytology were identified.
RESULTS
Among the 67 patients with a malignant disease (48 cholangiocarcinoma, 6 gallbladder cancer, 5 pancreatic cancer, 5 ampulla of Vater cancer, and 3 other types), 36 (53.7%) had atypical or suspicious cells on brush cytology. Among these, the factors that independently correlated with malignant strictures were stricture length (odds ratio [OR], 5.259; 95% confidence interval [CI], 1.802- 15.294) and elevated carbohydrate antigen 19-9 (CA19-9) (OR, 3.492; 95% CI, 1.242-9.815), carcinoembryonic antigen (CEA) (OR, 4.909; 95% CI, 1.694-14.224), alkaline phosphatase (ALP) (OR, 3.362; 95% CI, 1.207-9.361), and gamma-glutamyl transpeptidase (rGT) (OR, 4.318; 95% CI, 1.512-12.262).
CONCLUSIONS
Elevated levels of CA19-9, CEA, ALP, and rGT and stricture length are associated with malignant strictures in patients with indeterminate biliary strictures on imaging and atypical or suspicious cells on brush cytology.

Keyword

Brush cytology; Biliary stricture; Atypical cell; Suspicious cell

MeSH Terms

Alkaline Phosphatase
Ampulla of Vater
Carcinoembryonic Antigen
Cholangiocarcinoma
Constriction, Pathologic*
Diagnosis
Gallbladder Neoplasms
gamma-Glutamyltransferase
Humans
Pancreatic Neoplasms
Retrospective Studies
Alkaline Phosphatase
Carcinoembryonic Antigen
gamma-Glutamyltransferase

Figure

  • Fig. 1. Receiver operator curves and corresponding area under curves for carbohydrate antigen 19-9 (CA19-9), carcinoembryonic antigen (CEA), alkaline phosphatase (ALP), gamma-glutamyl transpeptidase (rGT) and length of stricture.


Cited by  1 articles

How Can We Differentiate Malignant Biliary Strictures from Clinically Indeterminate Biliary Strictures?
Eui Joo Kim, Jae Hee Cho
Clin Endosc. 2019;52(2):95-96.    doi: 10.5946/ce.2019.034.


Reference

1. Mahmoudi N, Enns R, Amar J, AlAli J, Lam E, Telford J. Biliary brush cytology: factors associated with positive yields on biliary brush cytology. World J Gastroenterol. 2008; 14:569–573.
Article
2. Tanaka H, Matsusaki S, Baba Y, et al. Usefulness of endoscopic transpapillary tissue sampling for malignant biliary strictures and predictive factors of diagnostic accuracy. Clin Endosc. 2018; 51:174–180.
Article
3. Parsi MA, Deepinder F, Lopez R, Stevens T, Dodig M, Zuccaro G. Factors affecting the yield of brush cytology for the diagnosis of pancreatic and biliary cancers. Pancreas. 2011; 40:52–54.
Article
4. Kawada N, Uehara H, Katayama K, et al. Combined brush cytology and stent placement in a single session for presumed malignant biliary stricture. J Gastroenterol Hepatol. 2011; 26:1247–1251.
Article
5. Navaneethan U, Singh T, Gutierrez NG, et al. Predictors for detection of cancer in patients with indeterminate biliary stricture and atypical cells on endoscopic retrograde brush cytology. J Dig Dis. 2014; 15:268–275.
Article
6. Navaneethan U, Njei B, Lourdusamy V, Konjeti R, Vargo JJ, Parsi MA. Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: a systematic review and meta-analysis. Gastrointest Endosc. 2015; 81:168–176.
Article
7. Victor DW, Sherman S, Karakan T, Khashab MA. Current endoscopic approach to indeterminate biliary strictures. World J Gastroenterol. 2012; 18:6197–6205.
Article
8. Lee HJ, Cho KB. Diagnosis of malignant biliary stricture: more is better. Clin Endosc. 2018; 51:115–117.
Article
9. Temiño López-Jurado R, Cacho Acosta G, Argüelles Pintos M, Rodríguez Caravaca G, Lledó Navarro JL, Fernández Rodríguez C. Diagnostic yield of brush cytology for biliary stenosis during ERCP. Rev Esp Enferm Dig. 2009; 101:385–389, 390-394.
Article
10. Papachristou GI, Smyrk TC, Baron TH. Endoscopic retrograde cholangiopancreatography tissue sampling: when and how? Clin Gastroenterol Hepatol. 2007; 5:783–790.
Article
11. Ohshima Y, Yasuda I, Kawakami H, et al. EUS-FNA for suspected malignant biliary strictures after negative endoscopic transpapillary brush cytology and forceps biopsy. J Gastroenterol. 2011; 46:921–928.
Article
12. Fritcher EG, Kipp BR, Halling KC, et al. A multivariable model using advanced cytologic methods for the evaluation of indeterminate pancreatobiliary strictures. Gastroenterology. 2009; 136:2180–2186.
Article
13. Park MS, Kim TK, Kim KW, et al. Differentiation of extrahepatic bile duct cholangiocarcinoma from benign stricture: findings at MRCP versus ERCP. Radiology. 2004; 233:234–240.
Article
14. Baron TH, Harewood GC, Rumalla A, et al. A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures. Clin Gastroenterol Hepatol. 2004; 2:214–219.
Article
15. Stewart CJ, Mills PR, Carter R, et al. Brush cytology in the assessment of pancreatico-biliary strictures: a review of 406 cases. J Clin Pathol. 2001; 54:449–455.
Article
16. DeWitt J, Misra VL, Leblanc JK, McHenry L, Sherman S. EUS-guided FNA of proximal biliary strictures after negative ERCP brush cytology results. Gastrointest Endosc. 2006; 64:325–333.
Article
17. Liang B, Zhong L, He Q, et al. Diagnostic accuracy of serum CA19-9 in patients with cholangiocarcinoma: a systematic review and meta-analysis. Med Sci Monit. 2015; 21:3555–3563.
Article
18. Li Y, Li DJ, Chen J, et al. Application of joint detection of AFP, CA19-9, CA125 and CEA in identification and diagnosis of cholangiocarcinoma. Asian Pac J Cancer Prev. 2015; 16:3451–3455.
Article
19. Qin XL, Wang ZR, Shi JS, Lu M, Wang L, He QR. Utility of serum CA19-9 in diagnosis of cholangiocarcinoma: in comparison with CEA. World J Gastroenterol. 2004; 10:427–432.
Article
20. Zare M, Kargar S, Akhondi M, Mirshamsi MH. Role of liver function enzymes in diagnosis of choledocholithiasis in biliary colic patients. Acta Med Iran. 2011; 49:663–666.
21. Hayat JO, Loew CJ, Asrress KN, McIntyre AS, Gorard DA. Contrasting liver function test patterns in obstructive jaundice due to biliary strictures [corrected] and stones. QJM. 2005; 98:35–40.
22. Goldberg DM. Structural, functional, and clinical aspects of gamma-glutamyltransferase. CRC Crit Rev Clin Lab Sci. 1980; 12:1–58.
Full Text Links
  • CE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr